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Diabetes mellitus is accompanied by hormonal and neurochemical changes that can be asso-
ciated with anxiety and depression. Both diabetes and depression negatively interact, in that
depression leads to poor metabolic control and hyperglycemia exacerbates depression. We hy-
pothesize one novel vanadium complex of vanadium-enriched Cordyceps sinensis (VECS), which
is beneficial in preventing depression in diabetes, and influences the long-term course of gly-
cemic control. Vanadium compounds have the ability to imitate the action of insulin, and this
mimicry may have further favorable effects on the level of treatment satisfaction and mood.
C. sinensis has an antidepressant-like activity, and attenuates the diabetes-induced increase
in blood glucose concentrations. We suggest that the VECS may be a potential strategy for
contemporary treatment of depression and diabetes through the co-effect of C. sinensis and
vanadium. The validity of the hypothesis can most simply be tested by examining blood glucose
levels, and swimming and climbing behavior in streptozotocin-induced hyperglycemic rats.
Keywords: antidepressants – vanadium enriched Cordyceps sinensis – diabetes – depression –
high blood sugar-diabetes
Introduction
Diabetes mellitus is accompanied by hormonal and
neurochemical changes that can be associated with anx-
iety and depression (1, 2). The prevalence of depression is
18% higher in diabetic patients than in the general
population, and only 33% of depression cases among
diabetic patients are diagnosed and treated (3, 4). These
associations may be related to the increased risk of de-
pressive symptoms in individuals with diabetes, increased
risk of Type 2 diabetes in individuals with depressive
symptoms or both. Growing evidence from clinical stu-
dies indicate that diabetic patients with major depression
demonstrate poor adherence to antidiabetic regimens,
have poor glycemic control, and are at an increased
risk for retinopathy (5) and macrovascular complica-
tions (6).
The two processes, diabetes and depression, negatively
interact, in that depression leads to poor metabolic con-
trol and hyperglycemia exacerbates depression. A con-
temporary treatment approach advocates an aggressive
stance toward both diabetes and depression management
to optimize global outcome. However, to our knowledge,
an algorithm incorporating the management of both has
not been discovered or reported in the literature to date.
It is worthwhile to investigate one potential strategy
of contemporary treatment toward both diabetes and
depression. We hypothesize one novel vanadium complex
of vanadium-enriched Cordyceps sinensis (VECS), which
will be beneficial in preventing depression in diabetes
and also influence the long-term course of glycemic
control.
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Vanadium, glycemic control and depression
management
Vanadium, element number 23, atomic weight 50.94, is
normally present in very low concentrations (<108M)
in virtually all the cells in plants and animals. As a po-
tential therapeutic agent, in recent times, it is attracting
increasing attention. Vanadium compounds have the
ability to imitate the action of insulin (7, 8). Oral admin-
istration of inorganic vanadium salts has shown antidia-
betic activity in vitro (9), in vivo (10) and even in patients
(11). The improved metabolic control can improve the
mood and the insulin mimicry may have further favor-
able effects on the level of treatment satisfaction and
mood (12). Some evidence suggests that patients with
adequate glycemic control will have an improved sense
of well-being (13, 14).
Cordyceps sinensis, depression management
and glycemic control
Mushrooms and primarily basidiomycetous fungi are a
popular and valuable food, low in calories and high
in minerals, essential amino acids, vitamins and fibers
(15, 16). Some of them produce substances, which have
potential medical effects, and are called medicinal mush-
rooms (17–20).
Mushrooms are a low-calorie food with minimal fat
and are highly suitable for obese persons. With no
starch and low sugars, mushrooms might be considered
the ‘delight of diabetics’ (21). Cordyceps sinensis is a
fungus, and has been known as a traditional medicine
in China. Many studies have shown that C. sinensis pos-
sesses hypoglycemic (22, 23) and vasorelaxant activities
(24). Cordyceps sinensis has an antidepressant-like activity
and some of its constituents might act as adrenoceptor
and dopamine D2 receptor agonists or noradrenaline/
dopamine reuptake inhibitors (25). Fermented C. sinensis
improved the diabetes-induced decrease in serum insulin
concentration, and attenuated the diabetes-induced
increases in blood glucose concentrations (26).
Vanadium enriched Cordyceps sinensis
Using trace elements at lower doses, in combination with
fungus have been ascribed as one of the potent ways to
reduce trace elements-associated toxicity and maintain
their effect (27, 28). An important property of fungus is
the ability to take up and accumulate trace metals such as
cadmium, lead, arsenic, copper, nickel, silver, chromium,
and mercury in the body or mycelium of the fungus
(29–31). Taken together, these data suggest that fer-
mented fungus of C. sinensis rich in vanadium may be
beneficial in preventing depression in diabetes (Fig. 1).
Testing the hypothesis
The validity of the hypothesis can most simply be tested
by examining blood glucose levels and the swimming
and climbing behavior in streptozotocin-induced
hyperglycemic rats following VECS treatment.
Streptozotocin inhibits insulin secretion and causes a
state of insulin-dependent diabetes mellitus (32). The
streptozotocin-induced diabetic rats prematurely and
repeatedly present more intense immobility in the
forced swimming test, demonstrating their susceptibility
to behavioral alterations in this animal model (33).
Conclusions
In this article, we suggest that the VECS may be a
potential strategy for contemporary treatment of depres-
sion and diabetes through the co-effect of C. sinensis and
vanadium (Fig. 1). This hypothesis represents a com-
pletely novel area of study, which will lead to valuable
treatments for psychological disorders as well as physical
diseases.
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Figure 1. Diagram illustrating processing scheme of contemporary treatment approach of Vanadium and C. sinensis toward both diabetes and
depression.
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If the hypothesis is supported by further experimenta-
tion, it may improve people’s quality of life and reduce
the medical cost of our healthcare system.
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